Evidence map›Paper›PMID 41767265›Full record

ArticleiScience2026

Differentiation of mesenchymal stem/stromal cells into CD45

Robert M Rusch, Yo Mabuchi, Satoru Morikawa, Yoko Ogawa, Shigeto Shimmura

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Robert M RuschDepartment of Clinical Regenerative Medicine, Fujita Health University, Tokyo 144-0041, Japan.
Yo MabuchiDepartment of Clinical Regenerative Medicine, Fujita Health University, Tokyo 144-0041, Japan.
Satoru MorikawaDepartment of Dentistry and Oral Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.
Yoko OgawaDepartment of Ophthalmology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Shigeto ShimmuraDepartment of Clinical Regenerative Medicine, Fujita Health University, Tokyo 144-0041, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem/stromal cells (MSCs) are notable for their differentiation potential and immunomodulatory properties. They share several features with macrophages as well as fibrocytes. This study aimed to investigate the relationship between MSCs, fibrocytes, and macrophages, focusing on the hypothesis of a possible direct lineage. Particularly, the focus lies on a freshly isolated murine MSC population known as PαS cells, which were transplanted into irradiated recipients, resulting in cells expressing a macrophage-like phenotype with CD45, CD68, and CSF1R (also known as CD115) expression. Further analysis showed that PαS cells cultured in macrophage differentiation media acquired characteristics of M2 macrophages (CD45, CD68, and CD206) through interaction with CSF1R. These results were confirmed in several mouse strains and human MSCs. Single-cell RNA sequencing revealed macrophage-like populations among the PαS cells, demonstrating the phenotypic plasticity of non-cultured MSCs, giving into MSC potential roles in immune regulation and tissue repair.

Indexed as

Cell biologyImmunology

Identifiers

PMID41767265
PMCPMC12936835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.